First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
January 17, 2024 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
December 18, 2023 06:00 ET
|
First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Date and Time Announced for First Wave BioPharma CEO James Sapirstein’s Presentation at the 2023 BIO Investor Forum
October 10, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Solomon Partners to Expand Healthcare Group with Hiring of Karan Garg (KG) and Brad Hildebrand
October 02, 2023 11:50 ET
|
Solomon Partners
Solomon Partners to Expand Healthcare Group with Hiring of Karan Garg (KG) and Brad Hildebrand
4.9% CAGR for Gastrointestinal Drugs Market Size Worth $71.3Bn, Globally, by 2027 with Irritable Bowel Syndrome Segment Driving Growth During 2020-2027 | Report by The Insight Partners
July 11, 2023 10:55 ET
|
The Insight Partners
Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners latest study on "Gastrointestinal Drugs Market Size Report, Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug...
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
June 28, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
American College of Gastroenterology and American Gastroenterological Association Invest in Oshi Health to Accelerate Adoption of Hybrid Digestive Health Care
June 13, 2023 09:15 ET
|
Oshi Health
PORTLAND, Ore., June 13, 2023 (GLOBE NEWSWIRE) -- AHIP 2023 CONFERENCE -- Oshi Health today announced strategic investments by the American College of Gastroenterology (ACG) and the American...
Florida Medical Clinic Announces New Gastroenterology Service at Epperson/Watergrass
May 22, 2023 15:53 ET
|
Florida Medical Clinic
TAMPA, Fla., May 22, 2023 (GLOBE NEWSWIRE) -- Florida Medical Clinic announced today that it plans to add a Gastroenterology practice to its new Epperson/Watergrass Campus in July. The...
Oshi Health Raises $30M Series B Funding to Scale Access to Its Virtual Multidisciplinary Digestive Care
April 11, 2023 08:00 ET
|
Oshi Health
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that it has raised $30...
Dr. David Heydt Named Medical Director of Capital Digestive Care Laboratory
March 01, 2023 10:13 ET
|
Capital Digestive Care
Silver Spring, MD, March 01, 2023 (GLOBE NEWSWIRE) -- Capital Digestive Care has announced that David Heydt has been named medical director of Capital Digestive Care Laboratory effective March 1,...